Curated News
By: NewsRamp Editorial Staff
December 11, 2025
Wearable Devices Secures $750K for Neural Wristband Rehabilitation Pilot
TLDR
- Wearable Devices gains a $750,000 grant for a clinical pilot, potentially establishing its Mudra Link as a leading rehabilitation tool and creating a competitive edge in the medical tech market.
- The clinical pilot will use Wearable Devices' patented surface EMG technology in the Mudra Link wristband to quantitatively monitor neuro-muscular activity for grip-force control rehabilitation.
- This technology aims to improve accessibility and outcomes in therapy for patients with motor-cortex injuries, making rehabilitation more effective and enhancing their quality of life.
- A wristband that reads muscle signals is being tested to help patients regain hand control, blending AI wearables with advanced medical rehabilitation.
Impact - Why it Matters
This development represents a significant convergence of wearable technology and healthcare innovation that could transform rehabilitation for millions of patients worldwide. Approximately 15 million people suffer strokes annually, with many experiencing lasting motor impairments, while countless others face similar challenges from traumatic brain injuries, spinal cord injuries, and neurological conditions. Traditional rehabilitation methods often lack precise tracking capabilities and can be inaccessible due to cost or geographic limitations. The Mudra Link's application in clinical settings demonstrates how consumer-grade wearable technology can be adapted for medical purposes, potentially making sophisticated neuro-muscular monitoring more affordable and widely available. This advancement could lead to more personalized rehabilitation programs, better tracking of patient progress, and improved outcomes through data-driven therapy adjustments. Furthermore, successful implementation could accelerate the integration of AI-powered wearables across healthcare, creating new standards for remote patient monitoring and tele-rehabilitation services that became increasingly important during the pandemic and continue to evolve in modern healthcare delivery.
Summary
Wearable Devices Ltd. (NASDAQ: WLDS), a pioneering technology growth company specializing in AI-powered touchless sensing wearables, has secured a significant milestone with Israel Innovation Authority approval for a $750,000 budget to fund a clinical pilot at Soroka University Medical Center. This groundbreaking initiative will evaluate the company's Mudra Link neural wristband as a rehabilitation tool for patients suffering from impaired grip-force control following motor-cortex injuries. The project extends Wearable Devices' patented surface EMG technology into quantitative neuro-muscular monitoring, aiming to revolutionize force-control therapy by improving accessibility, tracking capabilities, and patient outcomes through innovative neural input technology.
The company's consumer products, including the Mudra Band and Mudra Link, represent cutting-edge advancements in human-computer interaction, enabling touch-free, intuitive control of digital devices through gesture recognition across multiple operating systems. Operating through a dual-channel model of direct-to-consumer sales and enterprise licensing collaborations, Wearable Devices serves both individual consumers seeking enhanced experiences in gaming, productivity, and extended reality (XR) environments, as well as business partners requiring advanced input solutions for immersive interactive environments. The company's technology is setting new standards for neural input within the rapidly growing XR ecosystem, positioning it at the forefront of creating seamless, natural user experiences across some of technology's most dynamic markets.
This news release was distributed through InvestorWire, a specialized communications platform within the Dynamic Brand Portfolio that provides advanced wire-grade press release syndication and comprehensive corporate communications solutions. For investors seeking the latest updates, the company maintains an active newsroom where additional information about Wearable Devices and its innovative technologies can be found. The clinical pilot represents a significant expansion of the company's technology applications beyond consumer electronics into the healthcare sector, potentially opening new markets while addressing critical rehabilitation needs for patients recovering from neurological injuries.
Source Statement
This curated news summary relied on content disributed by InvestorBrandNetwork (IBN). Read the original source here, Wearable Devices Secures $750K for Neural Wristband Rehabilitation Pilot
